GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 22, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK bought back some of its own stock on 5/21.
AI Summary
GSK plc announced on May 21, 2025, that it purchased a certain number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of share repurchases and does not contain significant new risks.
Key Players & Entities
- GSK plc (company) — The company making the share repurchase.
- Citigroup Global Markets Limited (company) — The corporate stockbroker acting on behalf of GSK plc.
- May 21, 2025 (date) — The date of the share purchase.
FAQ
What was the specific number of GSK plc ordinary shares purchased on May 21, 2025?
The filing states that a certain number of shares were purchased, but the exact quantity is not specified in the provided text.
What was the total dollar amount of the share repurchase by GSK plc on May 21, 2025?
The filing does not disclose the total dollar amount spent on the share repurchase.
Who acted as the corporate stockbroker for GSK plc in this transaction?
Citigroup Global Markets Limited acted as the corporate stockbroker for GSK plc.
What is the par value of GSK plc's ordinary shares?
The ordinary shares of GSK plc have a par value of 31 1/4 pence each.
Is this a routine filing for GSK plc?
Yes, this is a Form 6-K, which is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, often used for ongoing reporting requirements like share transactions.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 22, 2025 regarding GSK plc (GLAXF).